Evolution of systemic anti-cancer treatment

Abstract

Tailored to clinical and molecular characteristics of a patient’s management is the most promising direction in the evolution of systemic anti-cancer treatment. Recent observations show, that significant progress may be also rela­ted to the use of methods addressing the immune system of patients. The use of multidisciplinary management is important since, that represents combined administration of various pharmacological treatments as well as the use of loco-regional and systemic methods. The aim of this paper is to discuss the most important ways in the evolution of systemic anti-cancer treatment.